SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $283,000 | +5.2% | 5,200 | 0.0% | 0.34% | +10.6% |
| Q2 2017 | $269,000 | -20.6% | 5,200 | -3.7% | 0.31% | -15.9% |
| Q1 2017 | $339,000 | +18.9% | 5,400 | 0.0% | 0.37% | +22.0% |
| Q4 2016 | $285,000 | -1.0% | 5,400 | 0.0% | 0.30% | +11.4% |
| Q3 2016 | $288,000 | +32.1% | 5,400 | 0.0% | 0.27% | +33.8% |
| Q2 2016 | $218,000 | -11.7% | 5,400 | -1.8% | 0.20% | +5.7% |
| Q4 2015 | $247,000 | +16.5% | 5,500 | 0.0% | 0.19% | +13.5% |
| Q3 2015 | $212,000 | -20.3% | 5,500 | 0.0% | 0.17% | -6.1% |
| Q2 2015 | $266,000 | -21.3% | 5,500 | -39.6% | 0.18% | 0.0% |
| Q3 2014 | $338,000 | -2.9% | 9,100 | 0.0% | 0.18% | +4.6% |
| Q2 2014 | $348,000 | +52.6% | 9,100 | +82.0% | 0.17% | +43.0% |
| Q1 2014 | $228,000 | -50.5% | 5,000 | -56.7% | 0.12% | -51.8% |
| Q4 2013 | $461,000 | -0.9% | 11,550 | +9.0% | 0.25% | -4.9% |
| Q3 2013 | $465,000 | +39.6% | 10,600 | 0.0% | 0.26% | +40.4% |
| Q2 2013 | $333,000 | – | 10,600 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |